Advances in interventional mechanical thrombus extraction in lower extremity deep vein thrombosis
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 2
Abstract
Deep vein thrombosis (DVT) refers to the abnormal clotting of blood within deep veins, predominantly in the lower extremities. Its formation is primarily attributed to three key factors: venous stasis, a hypercoagulable state, and endothelial injury. Common risk factors include prolonged immobilization, post-surgical recovery, malignant tumor, pregnancy, hereditary thrombophilia and certain medications. The most significant complication of DVT is pulmonary embolism (PE), while chronic complications such as post-thrombotic syndrome (PTS) can also occur. In high-risk patients, thrombolytic therapy or inferior vena cava filters may be used to prevent PE. Advances in medical technology have led to the widespread use of percutaneous mechanical thrombectomy (PMT) devices, which provide a minimally invasive and effective method for removing venous thrombi. This article reviews recent developments in the clinical application of deep vein mechanical thrombus removal technologies, with a focus on the principles, therapeutic benefits, and clinical outcomes of various devices.
Authors and Affiliations
ZHU Di, MA Kun, ZHOU Tao,MIAO Qinghai, SHAO Zefeng
Keywords
Related Articles
- EP ID EP759935
- DOI 10.13429/j.cnki.cjcr.2025.02.003
- Views 22
- Downloads 0
Comparison of remimazolam versus propofol in combination with remifentanil in hysteroscopic surgery
"<b>Objective</b> To compare the anesthesia effect and hemodynamics of remimazolam versus propofol in combination with remifentanil in hysteroscopic surgery. <b>Methods</b> A total of 60 patients who underwent electi...
Predictive value of serum actinin-4, TFF1, and TGFBI for the prognosis of patients with primary hepatocellular carcinoma after transarterial chemoembolization
Objective To investigate the predictive value of serum actinin-4, trefoil factor 1 (TFF1), and transforming growth factor-β-induced protein (TGFBI) for the prognosis of patients with primary hepatocellular carcinoma (PHC...
Research progress of regorafenib in the treatment of colorectal cancer
Colorectal cancer (CRC) is a common malignant tumor of digestive tract with an increasing incidence and mortality worldwide, and most patients have lost the opportunity of surgical treatment once diagnosed. With the cont...
Immunotherapy effects of apatinib mesylate combined with toripalimab on triple-negative breast cancer mice
Objective To investigate the application and effects of apatinib mesylate combined with programmed death receptor-1 (PD-1) monoclonal antibody (mAb)—toripalimab in immunotherapy for triple negative breast cancer (TNBC). ...
Preoperative controlling nutritional status on the prognosis of postoperative gastric cancer patients： a Meta-analysis
<b>Objective</b> To evaluate the prognostic value of controlling nutritional status score (CONUT) in patients undergoing gastrectomy for gastric cancer. <b>Methods</b> CNKI, Wanfang, China Biomedical Literature Library,...